The heatmap indicated that 1p19q codeletion, IDH mutation status, chemotherapy, age, tumor grade, histology, and PRS type differed significantly between the high- and low-FDX1 groups (p < 0.05). The gene discussed is IDH1; the disease is neoplasm.